Patents by Inventor Samarth Kumar

Samarth Kumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190117560
    Abstract: A method of treating a patient in need of therapy with fentanyl or a salt thereof, the method comprising providing a ready-to-administer solution consisting essentially of fentanyl or a salt thereof as the sole active ingredient, a sugar or sugar alcohol and water for injection, the solution having a pH in the range of 3.5 to 7.5, and parenterally administering the solution to the patient.
    Type: Application
    Filed: December 19, 2018
    Publication date: April 25, 2019
    Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
  • Publication number: 20190105262
    Abstract: The present invention relates to an intravenous infusion dosage form comprising: an aqueous solution of pemetrexed or its pharmaceutically acceptable salt at a concentration ranging from 1.0 mg/ml to 20.0 mg/ml present in a multilayered flexible plastic infusion container, wherein the multilayered flexible plastic infusion container has an oxygen scavenger layer sandwiched between an outermost and an innermost layer of the container, the container being free of a polyamide and wherein the multilayered flexible plastic infusion container filled with the aqueous solution of pemetrexed is autoclavable.
    Type: Application
    Filed: October 10, 2018
    Publication date: April 11, 2019
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Samarth KUMAR, Ramaji Karshanbhai VARU, Nishit PATEL, Prashant KANE, Subhas Balaram BHOWMICK
  • Publication number: 20190070110
    Abstract: The present invention provides a parenteral dosage form consisting essentially of a solution filled in a container, the solution comprising amiodarone or its pharmaceutically acceptable salt and a sulfo-alkyl ether beta-cyclodextrin in an aqueous vehicle, wherein the solution has a pH in the range of about 2.4 to 3.9 and further wherein the dosage form is sterilized by subjecting the filled container to autoclaving.
    Type: Application
    Filed: March 3, 2017
    Publication date: March 7, 2019
    Inventors: Samarth KUMAR, Soni Maheshkumar PARASMAL, Milan Mohanbhai VASOYA, Prashant KANE, Subhas Balaram BHOWMICK, Rajamannar THENNATI
  • Patent number: 10206872
    Abstract: A method of treating a patient in need of therapy with fentanyl or a salt thereof, the method comprising providing a ready-to-administer solution consisting essentially of fentanyl or a salt thereof as the sole active ingredient, a sugar or sugar alcohol and water for injection, the solution having a pH in the range of 3.5 to 7.5, and parenterally administering the solution to the patient.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: February 19, 2019
    Assignee: SUN PHARMACUETICAL INDUSTRIES LTD.
    Inventors: Samarth Kumar, Prashant Kane, Subhas Balaram Bhowmick, Milan Natvarbhai Thakkar, Kandarp Maheshkumar Dave
  • Publication number: 20190046398
    Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.
    Type: Application
    Filed: October 12, 2018
    Publication date: February 14, 2019
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Kirti GANORKAR, Nishit PATEL, Ashish Anilrao DUBEWAR, Umeshkumar Mukeshbhai PATEL
  • Publication number: 20190008847
    Abstract: The present invention relates to a dosage form comprising an aqueous solution of a vinca alkaloid drug or its pharmaceutically acceptable salt in a flexible infusion container, and a light protective secondary packaging containing the flexible infusion container, wherein the dosage form is ready-to-infuse and wherein the aqueous solution is stable at room temperature.
    Type: Application
    Filed: August 1, 2016
    Publication date: January 10, 2019
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Subhas Balaram BHOWMICK, Prashant KANE, Samarth KUMAR, Ramaji Karshanbhai VARU, Nisarg Bipinchandra MISTRY, Swapnil Ramesh PATIL
  • Patent number: 10098813
    Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: October 16, 2018
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth Kumar, Prashant Kane, Balaram Subhas Bhowmick, Kirti Ganorkar, Nishit Patel, Anilrao Ashish Dubewar, Mukeshbhai Umeshkumar Patel
  • Publication number: 20180140563
    Abstract: The present invention relates to a ready-to-administer parenteral dosage form of norepinephrine which comprises an aqueous solution of norepinephrine, having an anti-oxidant which is not a sulfite anti-oxidant, wherein the dosage form is stable at room temperature for prolonged period of time.
    Type: Application
    Filed: January 19, 2018
    Publication date: May 24, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Rakesh THUMMAR, Shantaram PAWAR, Prashant KANE, Subhas Balaram BHOWMICK, Samarth KUMAR, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
  • Publication number: 20180064703
    Abstract: The present invention relates to an infusion dosage form comprising (i) an aqueous solution of morphine or its pharmaceutically acceptable salt as a sole active ingredient in a concentration ranging from about 0.1 mg/ml to about 10.0 mg/ml, filled in containers in volumes ranging from about 50 ml to about 250 ml, and having dissolved oxygen content of less than 2 ppm, (ii) the container being surrounded by an outer covering, and (iii) an inert gas or vacuum is present in the space between the container and outer covering, wherein the infusion dosage form is sterilized by autoclaving and is stable upon autoclaving, and further wherein the space between the container and outer covering does not have an oxygen scavenger pouch before or during autoclaving.
    Type: Application
    Filed: September 1, 2017
    Publication date: March 8, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
  • Publication number: 20180036310
    Abstract: The present invention relates to an intravenous infusion dosage form of pemetrexed or its pharmaceutically acceptable salt, having long term stability.
    Type: Application
    Filed: February 12, 2016
    Publication date: February 8, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Kirti GANORKAR, Nisarg Bipinchandra MISTRY, Ramaji Karshanbhai VARU
  • Patent number: 9757352
    Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.
    Type: Grant
    Filed: April 18, 2017
    Date of Patent: September 12, 2017
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Amar Kishorbhai Rana, Shantaram Pawar, Prashant Kane, Subhas Balaram Bhowmick, Maheshkumar Parasmal Soni, Milan Mohanbhai Vasoya, Samarth Kumar
  • Publication number: 20170216243
    Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.
    Type: Application
    Filed: April 18, 2017
    Publication date: August 3, 2017
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Amar Kishorbhai RANA, Shantaram PAWAR, Prashant KANE, Subhas Balaram BHOWMICK, Maheshkumar Parasmal SONI, Milan Mohanbhai VASOYA, Samarth KUMAR
  • Patent number: 9642828
    Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: May 9, 2017
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Amar Kishorbhai Rana, Shantaram Pawar, Prashant Kane, Subhas Balaram Bhowmick, Maheshkumar Parasmal Soni, Milan Mohanbhai Vasoya, Samarth Kumar
  • Publication number: 20160367476
    Abstract: A method of treating a patient in need of therapy with fentanyl or a salt thereof, the method comprising providing a ready-to-administer solution consisting essentially of fentanyl or a salt thereof as the sole active ingredient, a sugar or sugar alcohol and water for injection, the solution having a pH in the range of 3.5 to 7.5, and parenterally administering the solution to the patient.
    Type: Application
    Filed: June 17, 2016
    Publication date: December 22, 2016
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Samarth KUMAR, Prashant KANE, Subhas Balaram BHOWMICK, Milan Natvarbhai THAKKAR, Kandarp Maheshkumar DAVE
  • Publication number: 20160081972
    Abstract: The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer.
    Type: Application
    Filed: September 21, 2015
    Publication date: March 24, 2016
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Amar Kishorbhai RANA, Shantaram PAWAR, Prashant KANE, Subhas Balaram BHOWMICK, Maheshkumar Parasmal SONI, Milan Mohanbhai VASOYA, Samarth KUMAR
  • Publication number: 20160058663
    Abstract: The present invention relates to a method for enabling hospitals or clinics to administer a dose of a drug to patients in need thereof while avoiding steps of manipulation, dilution, reconstitution, dispensing, sterilization, transfer, handling or compounding before intravenous administration. The present invention further relates to a perfusion system comprising different sets of perfusion containers, each container comprising a ready-to-infuse, stable, sterile, aqueous perfusion solution of a drug, wherein the set of perfusion containers alone or in combination provides for direct intravenous administration of a desired dose of the drug to a patient in need thereof, such that the delivered dose is equal to or within ±5% of the calculated dose.
    Type: Application
    Filed: September 2, 2015
    Publication date: March 3, 2016
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth KUMAR, Prashant KANE, Balaram Subhas BHOWMICK, Kirti GANORKAR, Nishit PATEL, Anilrao Ashish DUBEWAR, Mukeshbhai Umeshkumar Patel
  • Patent number: 9241948
    Abstract: A large volume infusion dosage form of gemcitabine, comprising a stable large volume solution of gemcitabine or its pharmaceutically acceptable salt in an aqueous vehicle filled in a large volume infusion container, wherein the solution is ready-to-be-infused.
    Type: Grant
    Filed: April 26, 2013
    Date of Patent: January 26, 2016
    Assignee: Sun Pharmaceutical Industries Ltd.
    Inventors: Samarth Kumar, Prashant Kane, Alok B. Namdeo, Subhas B Bhowmick, Kirti Ganorkar
  • Publication number: 20130288994
    Abstract: A large volume infusion dosage form of gemcitabine, comprising a stable large volume solution of gemcitabine or its pharmaceutically acceptable salt in an aqueous vehicle filled in a large volume infusion container, wherein the solution is ready-to-be-infused.
    Type: Application
    Filed: April 26, 2013
    Publication date: October 31, 2013
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Samarth Kumar, Prashant Kane, Alok B. Namdeo, Subhas B. Bhowmick, Kirti Ganorkar